Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
Stable expression over 15 generations with rapid cell line development in just 3 months. Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
Our promise to you: Guaranteed product quality, expert customer support.
24x7 CUSTOMER SERVICE
CONTACT US TO ORDER
Creative Biogene COVID-19 Research Solutions
The first decade of the 21st century came to an end with a horrible global pandemic, caused by the outbreak of a coronavirus species that has not been known to humans. Known previously as the "2019-nCoV", the species was officially named by the World Health Organization (WHO) in February, 2020 as COVID-19, an acronym for "Coronavirus Disease 2019".
The pandemic has been rapidly developing and spreading across the planet, rampaging cities on every continents and claiming horrific loss of innocent lives. With researchers and scientists around the world working closely together, striving diligently for their quests for solutions that could bring an end to this tragedy, Creative Biogene also wishes to make her own contribution to this battle against COVID-19. Comprehensive and cautious consideration had been given prior to the centralization of our current resources on COVID-19-related services being initiated. Creative Biogene is now dedicated to providing supportive services and products to both academics and industries with our long-term commitments for our clients to provide them with the best we could possibly do. The four major aspects of our service are shown down below.
Patients suffering from pneumonia caused by COVID-19 infection tend to exhibit symptoms resembling those that are normally found on individuals infected by seasonal influenza viruses. The deceptive nature of the virus made accurate distinguish between patients infected by COVID-19 from those who just had seasonal flu particularly challenging. Common symptoms found in clinical applications includes: fever, chest tightness, and fatigue. A small portion of individuals who are immunocompromised are highly susceptible to development of acute severe respiratory syndrome, or even mortality.
Creative Biogene promises to provide scientists and clinicians from all nations services and products that could potentially facilitate your research for successful treatment or vaccination for COVID-19 infection. Service and product categories are listed below. For more details on each item, please click on the links and you are always welcome to contact us. We are looking forward to being a reliable partner to your exciting research.
* For research use only. Not intended for any clinical use.